JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
PENN Entertainment
PENN
$1.98B
| $846K | ﹤0.01% |
57,349
-1,069,725
| -95% | -$16.7M |
2015 Q1
43 quarters
|
|
4527
indie Semiconductor
INDI
$688M
| $844K | ﹤0.01% |
239,151
-3,105
| -1% | -$13.6K |
2021 Q4
16 quarters
|
|
4528
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.35B
| $844K | ﹤0.01% |
5,276
-288
| -5% | -$46.1K |
2022 Q4
12 quarters
|
|
4529
PubMatic
PUBM
$839M
| $842K | ﹤0.01% |
94,931
-253,254
| -73% | -$2.21M |
2020 Q4
20 quarters
|
|
|
AKRE
4530
Akre Focus ETF
AKRE
$4.74B
| $840K | ﹤0.01% |
+12,822
| New | +$830K |
2025 Q4
0 quarters
|
|
4531
Fox Factory Holding Corp
FOXF
$784M
| $839K | ﹤0.01% |
49,041
-6,265
| -11% | -$119K |
2017 Q2
34 quarters
|
|
4532
BayCom
BCML
$341M
| $836K | ﹤0.01% |
28,427
-7,258
| -20% | -$210K |
2018 Q2
30 quarters
|
|
|
FCRS
4533
FutureCrest Acquisition Corp
FCRS
$368M
| $834K | ﹤0.01% |
+82,588
| New | +$835K |
2025 Q4
0 quarters
|
|
|
MAZE
4534
Maze Therapeutics
MAZE
$1.47B
| $829K | ﹤0.01% |
20,007
+12,117
| +154% | +$416K |
2025 Q1
3 quarters
|
|
4535
PUT
Agios Pharmaceuticals
AGIO
$1.9B
| $825K | ﹤0.01% |
30,300
+11,900
| +65% | +$418K |
2025 Q2
2 quarters
|
|
4536
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$553M
| $824K | ﹤0.01% |
5,168
-29,102
| -85% | -$4M |
2025 Q3
1 quarter
|
|
4537
XPEL
XPEL
$1.24B
| $823K | ﹤0.01% |
16,491
-67,769
| -80% | -$2.83M |
2020 Q2
22 quarters
|
|
4538
Wolfspeed
WOLF
$1.87B
| $820K | ﹤0.01% |
47,124
+43,111
| +1,074% | +$989K |
2017 Q1
35 quarters
|
|
4539
Vanguard Long-Term Bond ETF
BLV
$5.42B
| $820K | ﹤0.01% |
11,798
-280,574
| -96% | -$19.9M |
2021 Q1
19 quarters
|
|
4540
Bioventus
BVS
$897M
| $819K | ﹤0.01% |
110,090
-4,687
| -4% | -$33.7K |
2021 Q1
19 quarters
|
|
4541
State Street SPDR S&P Semiconductor ETF
XSD
$3.25B
| $818K | ﹤0.01% |
2,545
-4
| -0.2% | -$1.32K |
2015 Q1
43 quarters
|
|
|
4542
CALL
Agios Pharmaceuticals
AGIO
$1.9B
| $817K | ﹤0.01% |
+30,000
| New | +$1.05M |
2025 Q4
0 quarters
|
|
4543
iShares US Transportation ETF
IYT
$2.07B
| $813K | ﹤0.01% |
10,909
-79,585
| -88% | -$5.78M |
2013 Q2
50 quarters
|
|
4544
Schwab Fundamental International Small Company Index ETF
FNDC
$3.09B
| $812K | ﹤0.01% |
18,216
-691
| -4% | -$30.7K |
2022 Q3
13 quarters
|
|
|
NOAH
4545
Noah Holdings
NOAH
$535M
| $811K | ﹤0.01% |
80,788
+54,298
| +205% | +$590K |
2025 Q3
1 quarter
|
|
4546
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.32B
| $807K | ﹤0.01% |
4,498
+1,264
| +39% | +$222K |
2022 Q2
14 quarters
|
|
4547
Avalo Therapeutics
AVTX
$804M
| $807K | ﹤0.01% |
44,431
+42,858
| +2,725% | +$723K |
2023 Q4
8 quarters
|
|
4548
PUT
Futu Holdings
FUTU
$14.3B
| $805K | ﹤0.01% |
4,900
-17,000
| -78% | -$2.92M |
2025 Q1
3 quarters
|
|
|
ELVR
4549
Elevra Lithium Ltd
ELVR
$716M
| $804K | ﹤0.01% |
15,300
-4,804
| -24% | -$165K |
2025 Q3
1 quarter
|
|
4550
Amylyx Pharmaceuticals
AMLX
$3.55B
| $804K | ﹤0.01% |
66,547
+30,703
| +86% | +$417K |
2022 Q1
15 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.